Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

501 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of mammalian target of rapamycin inhibitors in systemic mastocytosis: A nationwide French pilot study.
Moraly J, Rossignol J, Rouzaud C, Gabas T, Bouktit H, Lhermitte L, Canioni D, Fraitag S, Bruneau J, Barete S, Suarez F, Ballul T, Meni C, Polivka L, Terriou L, Launay D, Bouillet L, Gaudy-Marqueste C, Gousseff M, Le Mouel E, Neel A, Ranta D, Jaussaud R, Guilpain P, Frenzel L, Agopian J, Dubreuil P, Greco C, Dimicoli-Salazar S, Heiblig M, Gourguechon C, Tournilhac O, Javier RM, Castelain F, Cabrera Q, Gourin MP, Wierzbicka-Hainaut E, Torregrosa-Diaz JM, Bulai C, Lavigne C, Hoarau C, Arock M, Damaj G, Lortholary O, Hermine O; CEREMAST network. Moraly J, et al. Among authors: launay d. Am J Hematol. 2024 Jun;99(6):1095-1102. doi: 10.1002/ajh.27323. Epub 2024 Apr 6. Am J Hematol. 2024. PMID: 38581211 Free article.
Severe adult hemophagocytic lymphohistiocytosis (HLHa) correlates with HLH-related gene variants.
Bloch C, Jais JP, Gil M, Boubaya M, Lepelletier Y, Bader-Meunier B, Mahlaoui N, Garcelon N, Lambotte O, Launay D, Larroche C, Lazaro E, Liffermann F, Lortholary O, Michel M, Michot JM, Morel P, Cheminant M, Suarez F, Terriou L, Urbanski G, Viallard JF, Alcais A, Fischer A, de Saint Basile G, Hermine O; French HLH Study Group. Bloch C, et al. Among authors: launay d. J Allergy Clin Immunol. 2024 Jan;153(1):256-264. doi: 10.1016/j.jaci.2023.07.023. Epub 2023 Sep 9. J Allergy Clin Immunol. 2024. PMID: 37678575 Free article.
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?
Scherlinger M, Nocturne G, Radic M, Launay D, Richez C, Bousso P, Forcade E, Meyer A, Jorgensen C, Bigenwald C, Cornec D, Sibilia J, Choquet S, Martin T, Belot A, Jouret M, Bitoun S, Amoura Z, Hermine O, Mariette X, Donnadieu E, Avouac J; Club for Innovative Immunotherapies in Immune-mediated Inflammatory diseases (C3I). Scherlinger M, et al. Among authors: launay d. Lancet Rheumatol. 2025 Jun;7(6):e434-e447. doi: 10.1016/S2665-9913(24)00377-1. Epub 2025 Mar 26. Lancet Rheumatol. 2025. PMID: 40157379 Review.
Absence of functional autoantibodies in systemic sclerosis: is now the right time to broaden reactome analysis? Comment on "Absence of Functional Autoantibodies Targeting Angiotensin II Receptor Type 1 and Endothelin-1 Type A Receptor in Circulation and Purified IgG From Patients With Systemic Sclerosis" published in Arthritis Rheumatology.
Chepy A, Dubucquoi S, Launay D, Sobanski V. Chepy A, et al. Among authors: launay d. Arthritis Rheumatol. 2025 Jun 30. doi: 10.1002/art.43305. Online ahead of print. Arthritis Rheumatol. 2025. PMID: 40583579 No abstract available.
[Assessment of internship sites in Internal Medicine and Clinical Immunology, 7 years after the Residency Training Program Reform: Findings from a 2024 year-end survey in France].
Mouthon L, Sève P, Agard C, André M, Andrès E, Aouba A, Benhamou Y, Bonnotte B, Bouillet L, Cathébras P, Cohen-Aubart F, Deligny C, Kaplanski G, Duhaut P, Launay D, Lavigne C, Lazaro E, Le Moigne E, Lescoat A, Ly K, Magy-Bertrand N, Maillot F, Martin M, Martis N, Moulinet T, Pugnet G, Raffray L, Roubille C, Servettaz A, Rauzy O. Mouthon L, et al. Among authors: launay d. Rev Med Interne. 2025 Jun 25:S0248-8663(25)00656-3. doi: 10.1016/j.revmed.2025.06.008. Online ahead of print. Rev Med Interne. 2025. PMID: 40571448 French.
Safety profile of JAK inhibitors in inflammatory or autoimmune diseases.
Moreau J, Chikhoune L, Poggi C, Stabler S, Letarouilly JG, Hachulla É, Launay D. Moreau J, et al. Among authors: launay d. Rev Med Interne. 2025 Jul;46(7):386-396. doi: 10.1016/j.revmed.2025.06.003. Epub 2025 Jun 24. Rev Med Interne. 2025. PMID: 40562664 Free article. Review.
501 results